<DOC>
	<DOCNO>NCT01268371</DOCNO>
	<brief_summary>To compare safety efficacy coronary stenting everolimus-eluting stent ( Promus Element® ) biolimus-eluting stent biodegradable polymer ( Nobori® )</brief_summary>
	<brief_title>Comparison Biolimus-eluting Biodegradable Polymer , Everolimus-eluting Sirolimus-eluting Coronary Stents</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<criteria>Significant coronary artery stenosis ( &gt; 50 % visual estimate ) Stable angina , unstable angina , NonST elevation myocardial infarction ( NSTEMI ) document silent ischemia Patients eligible intracoronary stenting age ≥ 20 year old ST segment elevation myocardial infarction ( within 24 hour ) Low ejection fraction ( &lt; 25 % ) Cardiogenic shock History bleeding diathesis know coagulopathy Limited lifeexpectancy ( less 1 year ) due combine serious disease Contraindication heparin , sirolimus , everolimus biolimus Contraindication aspirin clopidogrel Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Coronary artery disease</keyword>
	<keyword>Stent</keyword>
</DOC>